AXA World Funds - Global High Yield Bonds A Distribution EUR (Hedged)
Sub-fund of AXA World Funds (SICAV domiciled in Luxembourg)
Key Information
Legal Documents
Performance
Analysis

Fund Profile

Category: SICAV

Investment Objective The Sub-Fund investment objective is firstly to seek high income and secondary capital growth by investing in a broadly international high yield corporate debt securities over a long term period. Investment Policy The Sub-Fund is actively managed in order to capture opportunities in international high yield corporate debt. The following investment decisions are undertaken after comprehensive macroeconomic and microeconomic analysis of the market: sector allocation geographical allocation credit curve positioning (the credit curve illustrates the relationship between investment term and credit yield) issuer selection instrument selection The Sub-Fund invests mainly in high yield fixed or floating rate bonds issued mainly by US and European private companies. Such high return bonds have a rating lower than BBB- according to Standard & Poor’s, or equivalent rating (Moody's or any other rating agency), or are not rated. The selection of credit instruments is not exclusively and mechanically based on their publicly available credit ratings but also on an internal credit or market risk analysis. The decision to buy or sell assets is also based on other analysis criteria of the Investment Manager. Within the limit of 200% of the Sub-Fund’s net assets, the investment strategy may be achieved by direct investments or through derivatives, especially by entering into Credit Default Swaps. Derivatives may also be used for hedging purposes. The Share Class aims at hedging the foreign exchange risk resulting from the divergence between the reference currency of the Sub-Fund and the currency of this Share Class by using derivatives instruments whilst retaining the exposure to Investment Policy described above. Income For Capitalisation share classes (Cap), the dividend is reinvested. For Distribution share classes (Dis), the dividend is distributed. Sub-Fund Currency The reference currency of the Sub-Fund is USD. Investment Horizon This Sub-Fund may not be suitable for investors who plan to withdraw their contribution within 7 years. Processing of subscription and redemption orders The subscription, conversion or redemption orders must be received by the Registrar and Transfer Agent on any Valuation Day no later than 3 p.m. Luxembourg time. Orders will be processed at the Net Asset Value applicable to such Valuation Day. The investor's attention is drawn to the existence of potential additional processing time due to the possible involvement of intermediaries such as Financial Advisers or distributors. The Net Asset Value of this Sub-Fund is calculated on a daily basis.

Morningstar Rating
More information about the calculation of the Morningstar Ratings
Bronze
Bronze
Risk and reward profile
3
Lower Risk
Possible Lower
Returns
Higher Risk
Possible Higher
Returns
Key Information
Closing Price 13/12/201927.28
Morningstar categoryGlobal High Yield Bond - EUR Hedged
CurrencyEUR
Distribution statusDistributing
ISINLU0125750256
Inception Date12/03/2001
Minimum initial amount100.00 EUR
Fees And Charges
Entry feeNone
Purchase charge0.5% (subject to minimum)
Custody feeNone
Exit feeNone
Sale chargeNone
Ongoing charge1.53% of which 0.63% is paid by the Fund Manager to MeDirect
Fund management company
AddressAXA Funds Management S.A. 49, Avenue J.F. Kennedy Luxembourg 1855 Luxembourg
Manager NameCarl Whitbeck
Manager Start Date24/07/2012
Websitewww.axa-im.com
Total Net Assets (mil)972.47 EUR (30/11/2019)
UCITSYes
AdministratorState Street Bank International GmbH, Luxembourg Branch

Legal Documents

Prospectus
en 01/10/2019
Annual Report
en 31/12/2018
Semi Annual Report
en 30/06/2019
Morningstar Report
15/12/2019

Performance

Historical returns are no guarantee for future performances. Investing in Financial markets and securities involves risk. Past performance is not a guarantee of future results. Investment losses may occur and investors could lose some or all of their investment in the Fund.
Entry fees, purchase charges, custody fees, exit fees, sale charges and taxes are not included in the calculation of past performance. Ongoing charges (including management fees, administrative fees and other costs) have been taken in to account, as they are already included in the price/NAV of the fund.
Annualised performance in EUR
PeriodAnnualised returnDate
1 year6.01%13/12/2019
3 years2.21%13/12/2019
5 years2.68%13/12/2019
10 years5.62%13/12/2019
Since launch3.14%13/12/2019
Cumulative performance in EUR
Performance
YTD 01/01/20198.17%
1 month1.19%
3 months0.85%
6 months1.87%
Quarterly Returns
Q 1Q 2Q 3Q 4
20195.71%0.98%0.37%-
2018-1.10%-0.50%1.30%-5.18%
20171.93%1.33%0.97%-0.07%
20161.63%3.50%4.54%1.86%
20152.31%-0.42%-5.15%-2.05%
Dividend
Date ex dividendGross dividendPayment Date
28/12/20181.3011/01/2019
29/12/20171.1608/01/2018
13/06/20161.8620/06/2016
05/06/20152.1309/06/2015
06/06/20141.8511/06/2014
07/06/20131.9911/06/2013
08/06/20122.1612/06/2012
10/06/20112.3115/06/2011
11/06/20101.9215/06/2010
05/06/20092.4509/06/2009

Asset Allocation
% Long% Short% Net Assets
Stock0.00%0.00%0.00%
Bond96.46%0.00%96.46%
Cash93.39%90.42%2.97%
Other0.57%0.00%0.57%
Return/Risk Analysis
Risk Measurement1 Year3 Years5 Years
Standard Deviation
4.993.604.85
Sharpe Ratio
1.120.810.51
Sortino Ratio
2.191.420.81
Positive Months8.0021.0034.00
Negative Months4.0015.0026.00
Worst Month-2.17-2.17-3.10
World Regions
No Data Available
Stock Sector Weighting
No Data Available
Top 10 Holdings
HoldingSectorCountry% of Assets
Solera, LLC / Solera Finance, Inc. 10.5% 01/03/2024United States0.97
Ensemble S Merger Sub, Inc 9% 30/09/2023United States0.96
Watco Companies, L.L.C. / Watco Finance Corp. 6.38% 01/04/2023United States0.89
OPE KAG Finance Sub Inc 7.88% 31/07/2023United States0.89
BWAY Holding Company 7.25% 15/04/2025United States0.82
TransDigm, Inc. 6% 15/07/2022United States0.79
Bausch Health Companies Inc 7% 15/03/2024Canada0.77
Reynolds Group Issuer LLC. 15/07/2021United States0.76
Jaguar Holding Co II/Pharmaceutical Product Development LLC 6.38% 01/08/2023United States0.76
Sotera Health Topco Inc 8.12% 01/11/2021United States0.72
Classification of Morningstar Category
Ranking1 Year2 Years3 Years5 Years
Top 25%
Category above the average
Category below the average
Bottom 25%
Morningstar Style Box
Fixed Income Style
Large
Interest Rate Sensitivity
Mid
Small
Value
Blend
Growth
Credit Quality
27.28
Closing Price
All key information and documents must be reviewed before being able to Invest.